PFE
Pfizer Inc.
NYQ
$25.44
-0.10
(-0.41%)
Pullback · -1.11σ
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$145.0B
P/E ttm
19.4
Fwd P/E
9.0
Beta
0.30
Day range
$25.44
52w range
$24.83 – $28.75
Avg vol
37.1M
RSI(2)
5.7
ROE
8.3%
Net mgn
11.8%
FCF mgn
19.6%
Debt/Eq
0.72
Div yld
673.00%
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earn
2026-07-29
Matrix setup grades
Long
C
score 26 · tech 26 / 80 · support 0 / 20
KC1 lower, -1.02 ATR from EMA21 · doji
- · KC1 lower stretch — light dip
- · Doji — indecision, watch for reversal
- · Chop regime — mean-reversion favored both ways
Short
—
score 18 · tech 18 / 80 · support 0 / 20
below KC1 upper, -1.02 ATR from EMA21 · doji
- · Doji — indecision, watch for reversal
- · Chop regime — mean-reversion favored both ways
Options · swing
See more →
CALL
$26
2026-07-17
$0.65
PUT
$26
2026-07-17
$1.04
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-05-05
- EPS (act / est)
- 0.75 / 0.72
- Surprise
- +3.9%
- Next report
- 2026-07-29
About
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vy…